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Previous studies have shown that extracapsular dissection (ECD) is an alternative approach to superficial parotidectomy (SP) for
pleomorphic adenoma parotid tumours, associated with low recurrence rates equal to those following SP, but with significantly
reduced morbidity. However, if a malignant tumour masquerades as a clinically benign lump, this approach may be inappropriate. This
study addressed this question by analysing the outcome of 821 consecutive patients with parotid tumours treated at one centre over
40 years and with a median 12 (range 5–30) years follow-up. Tumours were classified as ‘simple’ (discrete, mobile, o 4cm: n¼662)
and ‘complex’ (deep, fixed, facial nerve palsy, X4cm: n¼159). Among the ‘simple’ or clinically benign tumours, 503 patients
underwent ECD; 159 patients underwent SP. In all, 32 (5%) clinically benign cases were subsequently revealed as malignant
histologies (ECD, 12; SP, 20). For each group, 5- and 10-year cancer-specific survival rates were 100 and 98%, respectively. There
were no differences in recurrence rates when subanalysed by surgical groups, but ECD was associated with significantly reduced
morbidity (P o 0.001). This study demonstrates that ECD is a viable alternative to superficial parotidectomy for the majority of
parotid tumours, associated with reduced morbidity without oncological compromise.
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Parotid tumours are uncommon, with the majority presenting as
discrete lumps arising within the superficial portion of the gland
(Renehan et al, 1996). Conventional teaching prescribes removal of
these tumours by superficial parotidectomy (SP), which encom-
passes facial nerve identification and en bloc removal of the
superficial portion of the gland (Langdon, 2001). Extracapsular
dissection (ECD) is an alternative approach to the removal of such
lumps involving meticulous dissection immediately outside the
tumour capsule while still preserving the facial nerve (Anderson,
1975; Gleave, 1995), and is distinct from enucleation. Based on the
traditional view that many parotid tumours (notably pleomorphic
adenomas) breach their capsule and so are theoretically at risk of
recurrence from surgery close to the capsule (the ‘tumour bud’
concept) (Thackray and Lucas, 1974; Lawson, 1989, Naeim et al,
1976), ECD has been received with caution. However, we have
previously demonstrated in 475 patients with pleomorphic
adenomas that ECD is associated with long-term low recurrence
rates (o 2%) comparable with SP, but fewer complications
(McGurk et al, 1996). Thus, in the practice of treating parotid
pleomorphic adenomas, ECD reduces morbidity without oncolo-
gical compromise. However, this procedure may not be appro-
priate for malignant tumours. The potential risk in ECD is
encountering a malignant tumour masquerading as a benign lump
– if this occurrence is common and the subsequent course of the
cancer is adversely affected, it would prohibit the use of ECD as an
alternative to SP for a simple parotid lump. This study addressed
this question by analysing the outcome of 821 consecutive patients
with parotid tumours treated at one centre over 40 years, and in
particular, focuses on outcome when the histology was a
carcinoma.
METHODS
Patients and pathology
Between 1952 and 1992, 821 patients with previously untreated
epithelial parotid neoplasia were treated at the Christie Hospital,
Manchester (Renehan et al, 1996, 1999; Gleave et al, 1979). The
preoperative diagnosis was made on clinical grounds; fine needle
aspiration cytology was not used. Tumours were classified by
clinical criteria into (i) ‘simple’, which are discrete, mobile, and
less than 4cm in diameter (for the purpose of this paper, this is
synonymous with ‘clinically benign’); and (ii) ‘complex’, which are
greater than 4cm and/or demonstrate fixity, facial nerve involve-
ment, palpable cervical nodes, or deep lobe involvement (McGurk
et al, 1995, 2001). For tumours with a malignant histology, simple
tumours equated to AJCC Stage I disease. Complex tumours were
not treated by ECD, and excluded from the analysis. The
histological diagnoses were updated in the mid-1970s in line with
the WHO classifications (Thackray and Sobin, 1972; Seifert and
Sobin, 1991). Median follow-up was 12 (range 5–32) years.
Treatment
Among the ‘simple’ tumours, 503 patients underwent ECD, 159
patients underwent SP. The choice of technique was made on
clinical criteria, namely mobility at surgery after raising the skin
flap. This procedure has been described in detail elsewhere
(Gleave, 1995). In this technique, the plane of dissection is within Received 29 January 2003; revised 4 July 2003; accepted 15 July 2003
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la compartment of loose areolar tissue approximately 2–3mm
from the tumour. This contrasts sharply with enucleation, which
breaches the capsule and removes the tumour within. Post-
operative adjuvant radiotherapy (RT) (McGurk et al, 1996;
Renehan et al, 1999) was used selectively, either for spillage of
benign tumour or for those malignant tumours with a positive
margin, spillage, adenoid cystic or high-grade carcinomas.
Statistical analysis
Comparisons of means were by Student’s t-test; proportions were
compared by w
2-tests or Fisher’s exact test, where expected frequencies
were less than five. Cancer-specific survival and recurrence rates were
calculated by the Kaplan–Meier method and differences tested by
log-rank (STATA version 7.0, College Station, CA, USA).
RESULTS
Basic characteristics
The baseline characteristics for the 821 tumours are outlined in
Table 1. The majority (662 or 81%) presented as ‘simple’ lumps, of
which only 32 or 5% proved to carcinomas. By contrast, two-thirds
of ‘complex’ tumours had a malignant histology. The pattern of
malignant histological types differed between ‘simple’ and ‘com-
plex’ tumours: notably, two-thirds of ‘simple’ lumps with
subsequent malignant histology were either acinic cell or low-
grade mucoepidermoid carcinoma.
Survival and recurrence rates
In the 32 patients with ‘simple’ lumps, which proved to be
carcinomas, 12 underwent ECD and 20 underwent SP. Following
surgery, over half of these patients received radiotherapy (ECD,
7/12: SP, 12/20)–the indications are shown in Table 2. While these
surgical groups were not randomly determined, the clinicopatho-
logical characteristics were broadly comparable (Table 3). The 5-
and 10-year cancer-specific survival rates were 100 and 98%,
respectively for ECD and SP (Figure 1A). Local recurrences
developed in six cases (ECD, 1: SP, 5), with no statistical difference
by log-rank testing between the two groups (Figure 1B). Only one
of the six cancer recurrences occurred in a patient who had
received both surgery and radiotherapy (Table 4); thus, radio-
therapy per se may have been a confounding factor in determining
recidivism.
Of the 630 patients with ‘simple’ lumps and benign histologies,
there were 10 recurrences at 15 years. Eight recurrences occurred
after 491 ECDs (1.7% at 15 years by life-table analysis); two
recurrences occurred after 139 SPs (1.8% at 15 years by life-table
analysis).
Morbidity
The complications by surgical groups and histological categories
are shown in Table 5. Among the 630 patients with a ‘simple’
tumour and benign pathology, ECD was associated with signifi-
cantly reduced morbidity compared with SP, including transient
facial palsy (P o 0.001), Frey’s syndrome (P o 0.001), and
amputation neuroma (P o 0.001) (Table 5). Salivary fistulae
developed without obvious causes in three patients treated by ECD
Table 2 Indications for postoperative radiotherapy among 19 patients
with stage I cancers
Extracapsular
dissection
(n¼7)
Superficial
parotidectomy
(n¼12)
Positive tumour margin 2 0
Close tumour margin 3 7
Tumour spillage 0 2
High-grade cancer 2 3
Adenoid cystic carcinoma 1 3
For some tumours, there may have been more than one indication for postoperative
radiotherapy.
Table 1 Characteristics of parotid tumours, Christie Hospital (1952–
1992)
Simple Complex
Total number 662 159
Median age (range) (years) 47 (5–87) 58 (25–85)
Males 267 (40) 83 (50)
Females 395 82
Benign histology 630 (95) 50 (31)
Pleomorphic adenoma 487 45
Warthin’s tumour 131 5
Monomorphic adenomas 12 0
Malignant histology
a 32 (5) 109 (69)
Acinic cell carcinoma 7 6
LG mucoepidemoid carcinoma 13 11
HG mucoepidermoid — 3
Basal cell adenocarcinoma — 1
Papillary cystoadenocarcinoma 2 2
Mucinous adenocarcinoma — 1
Adenocarcinoma, NOS — 16
Adenoid cystic carcinoma 5 28
Epithelial–myopeithelial ca. — 1
Ca. ex-pleomorphic adenoma 4 13
Squamous cell carcinoma — 7
Undifferentiated carcinoma 1 20
aFor malignant tumours, ‘simple’ lumps are equivalent to AJCC Stage I disease. Values
in parentheses are percentages unless otherwise indicated. See text for definitions of
‘simple’ and ‘complex’. NOS¼not otherwise specified; ca.¼carcinoma. LG¼low-
grade; HG¼high-grade.
Table 3 Clinicopathological characteristics of 32 stage I carcinomas
Extracapsular
dissection
(n¼12)
Superficial
parotidectomy
(n¼20) P-value
a
Age (mean) (s.d.) 44 (21) 52 (22) 0.33
Male : female 5:7 10:10
Size less than 2cm 4 (33) 5 (25) 0.70
Histology
Mucoepidermoid ca. 7 (58) 6 (30)
Acinic cell ca. 1 6 (30)
Adenoid cystic ca. 1 4 (20)
Other carcinomas 3 (25) 4 (20)
Malignant grade
Grade I 9 (75) 13 (65) 0.70
Grade II 1 3 (15)
Grade III 2 3 (15)
Positive tumour
margins
2 0 1.00
Close tumour margins 3 (25) 8 (40) 0.46
Perineural invasion 0 1
Tumour spillage 0 2 1.00
aStudent’s t-test, w
2, and Fisher’s exact tests as appropriate. Values in parentheses are
percentages. s.d.¼standard deviation.
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with ‘simple’ tumours and malignant histologies, complication
rates were generally higher, but this was based on small
patient numbers. There were no apparent differences between
ECD and SP.
DISCUSSION
This study has demonstrated that the majority of parotid tumours
present as a clinically benign lump, and of these, only 5%
subsequently prove to be carcinomas. This study establishes ECD
as a viable alternative surgical approach to superficial parotidect-
omy in such tumours, for it has the advantage of reduced
morbidity without untoward effects on oncological outcome.
The advantages of this study were large numbers of patients
treated with a similar surgical philosophy, and followed for a long
period. Thus, we were able to show that out of 662 clinically benign
parotid lumps, SP was avoided in 503 patients, and replaced with a
more conservative procedure carrying significantly less morbidity.
In adopting this conservative approach, there was a diagnostic
error rate of 32/662, with 12 patients treated ‘inappropriately’ by
ECD. The question was whether these ‘errors’ resulted in a poor
outcome, but this was not the case. The authors accept that the 12
patients should ideally have been treated by some form of
parotidectomy, and in such circumstances, seven patients may
have avoided RT–these represent the penalty paid for saving 503
patients the need to undergo parotidectomy.
The merit of classifying discrete parotid lumps into ‘simple’ or
‘complex’ is confirmed in this study. Using clinical judgement
alone, the assessment of 662 simple lumps (‘benign tumours’) was
correct in 95% of the cases. Following a final step of clinical
assessment at surgery, 12 of the 32 malignant tumours were
removed by ECD rather than SP (a clinical diagnostic error rate of
1.8%). This equates to a test sensitivity of 93% and a positive
predictive value of 95% (Altman and Bland, 1994). In theory, if
clinical assessment is supplemented with fine needle aspiration
cytology (McGurk and Hussain, 1997), these predictive values may
increase.
Only 5% of clinically benign parotid tumours were carcinomas
and notably two-thirds of these were low-grade cancers (acinic cell
and low-grade mucoepidermoid carcinomas). Half required post-
operative radiotherapy but this did not represent overtreatment of
Stage I disease (Frankenthaler et al, 1991). Irrespective of the
surgical approach, the long-term prognosis in this group was good.
A similar experience was reported by Nnochiri et al (1990), who
encountered 20 (4%) carcinomas unexpectedly in a series of 539
otherwise unremarkable parotid tumours. These tumours were
treated surgically as nonmalignant lumps, yet subsequently
followed a benign course.
As long-term low recurrence rates are now the norm for parotid
pleomorphic adenomas, there is an emerging trend towards low
morbidity surgery. Series employing either total parotidectomy or
formal superficial parotidectomy report high rates of transient
facial nerve palsy (15–70%) and Frey’s syndrome (13–66%)
(reviewed in Langdon, 2001). Recent studies have advocated a
more conservative parotidectomy, partial superficial parotidect-
omy, and report lower transient facial nerve rates (20–33%) and
Frey’s syndrome rates (7–20%) (Yamashita et al, 1993; Helmus,
1997; Leverstein et al, 1997; Snow, 2001). Still lower rates of
morbidity have been reported, following ECD (Anderson, 1975;
Martis, 1983; Prichard et al, 1992) with 3–11% transient facial
nerve palsy and 0–5% Frey’s syndrome. The very low rates of
gustatory sweating after ECD are presumably due to less
disruption of the parotid tissue. ECD also avoids the unsightly
complication of retromandibular depression frequently observed
after superficial parotidectomy.
As the needs for reducing morbidity and maintaining facial
aesthetics increase, ECD represents the current limit of conserva-
tive parotid surgery. A common feature of all minimally invasive
therapies is that the technique leaves little room for error. With
acceptance of these limitations, the findings of this study
demonstrate that ECD is a scientifically valid and oncologically
safe approach to the management of the clinically benign parotid
lump.
Table 4 Details of six recurrences from 32 cases with AJCC stage I
malignant disease
Summary of treatment, pathology, and outcome
Case 1 73 year, male; SP + postoperative RT; ca ex-PSA, Grade III; close
margin; LC at 23 months; died unrelated cause
Case 2 10 year, female; SP, no RT; mucoepidermoid ca.; Grade I; clear margins;
LA at 5 months; salvaged; disease-free at 12 years
Case 3 77 year, female; SP, no RT; adenoid cystic ca.; Grade II; close margin; LC
at 8 months; died of disease
Case 4 59 year, female; SP, no RT; adenoid cystic ca.; Grade II; clear margin; LC
at 157 months; salvaged
Case 5 59 year, male; SP, no RT; papillary adenocarcinoma; Grade I; clear
margin; LC at 113 months; salvaged; disease free at 5 years
Case 6 63 year, female; EDC, no RT; papillary adenocarcinoma; Grade I; clear
margin; LC at 168 months; salvaged; disease-free at 7 years
SP¼superficial parotidectomy; EDC¼extracapsular dissection; RT¼radiotherapy;
ca. ex-PSA¼carcinoma ex-pleomorphic adenoma; LC¼local recurrence.
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Figure 1 (A) Local recurrence rates and (B) cancer-specific survival
among the 32 patients with a carcinoma who presented as a ‘simple’ lump.
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